Elsevier

The Lancet Rheumatology

Volume 2, Issue 11, November 2020, Pages e653-e655
The Lancet Rheumatology

Comment
Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment

https://doi.org/10.1016/S2665-9913(20)30309-XGet rights and content

Cited by (0)

View Abstract